These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 20877608)
1. Medical management of overactive bladder. Ubee SS; Manikandan R; Singh G Indian J Urol; 2010 Apr; 26(2):270-8. PubMed ID: 20877608 [TBL] [Abstract][Full Text] [Related]
2. Anticholinergic drugs versus non-drug active therapies for overactive bladder syndrome in adults. Alhasso AA; McKinlay J; Patrick K; Stewart L Cochrane Database Syst Rev; 2006 Oct; (4):CD003193. PubMed ID: 17054163 [TBL] [Abstract][Full Text] [Related]
3. What Are the Short-term Benefits and Potential Harms of Therapeutic Modalities for the Management of Overactive Bladder Syndrome in Women? A Review of Evidence Under the Auspices of the European Association of Urology, Female Non-neurogenic Lower Urinary Tract Symptoms Guidelines Panel. Farag F; Sakalis VI; Arteaga SM; Sihra N; Karavitakis M; Arlandis S; Bø K; Cobussen-Boekhorst H; Costantini E; de Heide M; Groen J; Peyronnet B; Phé V; van Poelgeest-Pomfret ML; van den Bos TWL; van der Vaart H; Harding CK; Carmela Lapitan M; Imran Omar M; Nambiar AK Eur Urol; 2023 Sep; 84(3):302-312. PubMed ID: 37331921 [TBL] [Abstract][Full Text] [Related]
4. Pathophysiology of refractory overactive bladder. Chen LC; Kuo HC Low Urin Tract Symptoms; 2019 Sep; 11(4):177-181. PubMed ID: 30900373 [TBL] [Abstract][Full Text] [Related]
6. Overactive bladder (OAB): A symptom in search of a disease - Its relationship to specific lower urinary tract symptoms and conditions. Van Batavia JP; Combs AJ; Fast AM; Glassberg KI J Pediatr Urol; 2017 Jun; 13(3):277.e1-277.e4. PubMed ID: 28527720 [TBL] [Abstract][Full Text] [Related]
7. Understanding the elements of overactive bladder: questions raised by the EPIC study. Irwin DE; Abrams P; Milsom I; Kopp Z; Reilly K; BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602 [TBL] [Abstract][Full Text] [Related]
8. Female Urgency, Trial of Urodynamics as Routine Evaluation (FUTURE study): a superiority randomised clinical trial to evaluate the effectiveness and cost-effectiveness of invasive urodynamic investigations in management of women with refractory overactive bladder symptoms. Abdel-Fattah M; Chapple C; Guerrero K; Dixon S; Cotterill N; Ward K; Hashim H; Monga A; Brown K; Drake MJ; Gammie A; Mostafa A; Bladder Health UK; Breeman S; Cooper D; MacLennan G; Norrie J Trials; 2021 Oct; 22(1):745. PubMed ID: 34702331 [TBL] [Abstract][Full Text] [Related]
9. [Epidemiology and etiology of overactive bladder]. Hampel C; Gillitzer R; Pahernik S; Hohenfellner M; Thüroff JW Urologe A; 2003 Jun; 42(6):776-86. PubMed ID: 12851768 [TBL] [Abstract][Full Text] [Related]
10. Management of OAB in those over age 65. Natalin R; Lorenzetti F; Dambros M Curr Urol Rep; 2013 Oct; 14(5):379-85. PubMed ID: 23922134 [TBL] [Abstract][Full Text] [Related]
11. The effect of EMG biofeedback assisted pelvic floor muscle therapy on symptoms of the overactive bladder syndrome in women: A randomized controlled trial. Voorham JC; De Wachter S; Van den Bos TWL; Putter H; Lycklama À Nijeholt GA; Voorham-van der Zalm PJ Neurourol Urodyn; 2017 Sep; 36(7):1796-1803. PubMed ID: 27869312 [TBL] [Abstract][Full Text] [Related]
12. Management of Overactive Bladder in the Face of High Grade Prolapse. Guzman-Negron J; Vasavada S Curr Urol Rep; 2017 Feb; 18(2):12. PubMed ID: 28213857 [TBL] [Abstract][Full Text] [Related]
13. Myofascial Frequency Syndrome: A novel syndrome of bothersome lower urinary tract symptoms associated with myofascial pelvic floor dysfunction. Ackerman AL; Jackson NJ; Caron AT; Kaufman MR; Routh JC; Lowder JL medRxiv; 2023 Apr; ():. PubMed ID: 37131628 [TBL] [Abstract][Full Text] [Related]
15. Clinical Efficacy of Solifenacin in the Management of Diabetes Mellitus-Associated Versus Idiopathic Overactive Bladder Symptoms: A Multicenter Prospective Study. Choi H; Bae JH; Oh CY; Jeong SJ; Ko WJ; Choi JB; Seo JT; Lee DH; Kim JC; Lee KW; Kim YH Int Neurourol J; 2018 Mar; 22(1):51-57. PubMed ID: 29609421 [TBL] [Abstract][Full Text] [Related]
16. Drug treatment of overactive bladder: efficacy, cost and quality-of-life considerations. Hashim H; Abrams P Drugs; 2004; 64(15):1643-56. PubMed ID: 15257626 [TBL] [Abstract][Full Text] [Related]
17. Can surgical reconstruction of vaginal and ligamentous laxity cure overactive bladder symptoms in women with pelvic organ prolapse? Liedl B; Goeschen K; Sutherland SE; Roovers JP; Yassouridis A BJU Int; 2019 Mar; 123(3):493-510. PubMed ID: 29908047 [TBL] [Abstract][Full Text] [Related]
18. Do we need a new definition of the overactive bladder syndrome? ICI-RS 2013. Drake MJ Neurourol Urodyn; 2014 Jun; 33(5):622-4. PubMed ID: 24838519 [TBL] [Abstract][Full Text] [Related]
19. A ligamentous explanation for overactive bladder symptoms as defined by International Continence Society in the female. Petros P Cent European J Urol; 2018; 71(1):105-107. PubMed ID: 29732215 [TBL] [Abstract][Full Text] [Related]
20. Short-term Effects of a Systematized Bladder Training Program for Idiopathic Overactive Bladder: A Prospective Study. Lee HE; Cho SY; Lee S; Kim M; Oh SJ Int Neurourol J; 2013 Mar; 17(1):11-7. PubMed ID: 23610706 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]